Down Syndrome Critical Region Gene 8 (DSCR8)
MTAG2; C21orf65; CT25.1a; CT25.1b; MMA-1a; MMA-1b; Cancer/Testis Antigen Family 25 Member 1a; Malignant Melanoma-Associated 1
MMA1A and MMA1B transcripts in 20% of primary melanomas and in about 30% of melanoma metastasis, suggesting that expression emerges during malignant progression. PCR analysis also detected MMA1 in some tumor lesions of ileum, esophagus, and mammary gland, in several malignant melanoma cell lines, and in tumor cell lines of lung, liver, colon, and bladder.The full-length 91-amino acid MMA1A protein has a calculated molecular mass of 10 kD. It has 3 phosphorylation sites and 1 N-myristoylation site. The MMA1B transcript lacks exon 3 and encodes a deduced 37-amino acid protein that has a calculated molecular mass of 4 kD. MMA1B has a single phosphorylation site. RT-PCR analysis of 20 tissues detected both MMA1 transcripts in testis, but not in any other tissue examined. Nested PCR revealed low levels of MMA1A and/or MMA1B in some other tissues.
Organism species: Homo sapiens (Human)
- Customized Service n/a Recombinant Down Syndrome Critical Region Gene 8 (DSCR8) Recombinant Protein Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Down Syndrome Critical Region Gene 8 (DSCR8) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Down Syndrome Critical Region Gene 8 (DSCR8) Polyclonal Antibody Customized Service Offer
- Customized Service n/a CLIA Kit for Down Syndrome Critical Region Gene 8 (DSCR8) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for Down Syndrome Critical Region Gene 8 (DSCR8) ELISA Kit Customized Service Offer
